Management of Typhoid Fever with Hepatosplenomegaly and Leukocytosis
Start empiric intravenous ceftriaxone immediately while awaiting blood culture confirmation, as this patient presents with complicated typhoid fever evidenced by hepatosplenomegaly, and the leukocytosis (WBC 11,600) suggests potential complications requiring urgent antimicrobial therapy. 1
Immediate Antibiotic Management
Initiate IV ceftriaxone as first-line empiric therapy given the high probability of fluoroquinolone resistance (>70% of imported isolates) and the presence of hepatic involvement 1. The hepatosplenomegaly indicates systemic disease with organ involvement, which is a recognized complication occurring in 10-15% of typhoid cases and warrants aggressive treatment 1.
Key Treatment Points:
- Duration: Continue antibiotics for 14 days to minimize relapse risk (ceftriaxone relapse rate <8%) 1
- Alternative oral therapy: If fluoroquinolone sensitivity is confirmed AND nalidixic acid sensitivity is also present, fluoroquinolones can be used (but this is increasingly rare) 1
- Second-line oral option: Azithromycin if oral therapy becomes appropriate (relapse rate <3%) 1
Critical Diagnostic Workup
Obtain blood cultures immediately - these have the highest yield within the first week of symptoms (40-80% sensitivity) 1. The presence of hepatosplenomegaly is a classic finding in enteric fever 2.
Additional essential investigations:
- Liver function tests: Expect variable patterns - can show cholestatic hepatitis or hepatocellular dysfunction 3, 4, 5
- Complete blood count monitoring: The leukocytosis (11,600) is atypical but significant - leucocytosis (>8 x 10⁹/L) is associated with 70% complication rate 6
- Platelet monitoring: Current count of 162,000 is borderline; watch for progressive thrombocytopenia 3
Monitoring for Complications
The leukocytosis is a red flag - while leucopenia is classically described, leukocytosis significantly increases complication risk to 70% 6. Watch closely for:
- Gastrointestinal bleeding or perforation (more likely after >2 weeks of illness) 1
- Typhoid encephalopathy 1
- Progressive hepatic dysfunction - cholestatic hepatitis can develop 3, 4, 5
- Splenic complications including abscess formation 7
Adjunctive Therapy Considerations
Consider corticosteroids if severe hepatic dysfunction develops or if the patient becomes toxic/delirious 1, 3. Steroids may be helpful in severe cases with cholestatic hepatitis or hemophagocytic lymphohistiocytosis 3, 8.
Critical Pitfalls to Avoid
Do NOT rely on ciprofloxacin disc testing alone - sensitivity must also show nalidixic acid susceptibility to confirm true fluoroquinolone sensitivity 1
Do NOT use the Widal test - it lacks sensitivity and specificity 1
Do NOT assume leucopenia - only 24.6% of typhoid patients have leucopenia; leukocytosis predicts worse outcomes 6
Do NOT delay treatment if clinical suspicion is high and the patient appears unstable - empiric therapy should begin before culture confirmation 1
Supportive Care
- Fluid and electrolyte management: Essential given potential for hyponatremia and hypokalemia from gastrointestinal losses 3
- Monitor for dehydration: This increases mortality risk across all age groups 2
Follow-up Considerations
After completing 14 days of therapy, monitor for:
- Relapse (occurs in <8% with ceftriaxone) 1
- Chronic carrier state - requires separate management strategy 9
- Resolution of hepatosplenomegaly - should improve with appropriate treatment 7
The combination of hepatosplenomegaly with leukocytosis rather than the classic leucopenia suggests this patient has more severe disease requiring vigilant monitoring and potentially longer hospitalization 6, 7.